Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pituitary
Published in: Pituitary 4/2009

01-12-2009

Craniopharyngioma: historical notes

Authors: J. Lindholm, E. H. Nielsen

Published in: Pituitary | Issue 4/2009

Login to get access

Abstract

For centuries tumors have been described which today with some confidence can be diagnosed as craniopharyngiomas. It was not until 1904 Erdheim described what he called ‘hypophysial duct tumors’, and which Cushing later gave the name craniopharyngioma. The first operation for this neoplasm took place in 1909. It soon became evident that the outcome of surgery was rather dismal with high mortality and morbidity rates—even after corticosteroid therapy became available around 1950. Radiotherapy was introduced and later refined as radiosurgery. This paper presents a short survey of the accumulation of knowledge of craniopharyngiomas.
Literature
1.
2.
3.
Harrison MJ, Morgello S, Post KD (1994) Epithelial cystic lesions of the sellar and parasellar region: a continuum of ectodermal derivatives? J Neurosurg 80:1018–1025CrossRefPubMed
4.
5.
Abercrombie J (1828) Pathological and practical researches on diseases of the brain and the spinal cord. Waugh and Innes, Edinburgh, p 431
6.
7.
Mott FW, Barratt JOW (1899) Three cases of tumour of the third ventricle. Arch Neurol Psychiatry 1:417–440
8.
Saxer F (1902) Ependymepithel, Gliome und epitheliale Geschwülste des Centralenervensystems. Beitr Pathol Anat 32:276–350
9.
Erdheim J (1904) Über Hypophysenganggeschwülste und Hirncholesteatome. Sitzber math-naturwiss Klasse Kais Akad Wissenschaft 113(Abteil II):537–726
10.
Luschka H (1860) Der Hirnanhang und die Steissdrüse des Menschen. G Reimer, Berlin, pp 13–51
11.
Rathke H (1838) Uber die Entstehung der Glandula pituitaria. Arch Anat Physiol Wiss Med 5:482–485
12.
von Mihalkovics V (1875) Wirbelsaite und Hirnanhang. Arch mikr Anat 11:389–441CrossRef
13.
14.
15.
Carmichael HT (1931) Squamous epithelial rests in the hypophysis cerebri. Arch Neurol Psychiatry 26:966–975
16.
17.
Goldberg GM, Eshbaugh DE (1960) Squamous cell nests of the pituitary gland as related to the origin of craniopharyngiomas. A study of their presence in the newborn and infants up to age four. Arch Pathol 70:293–299PubMed
18.
Luse SA, Kernohan JW (1955) Squamous-cell rests of the pituitary gland. Cancer 8:623–628. doi:10.1002/1097-0142(1955)8:3<623::AID-CNCR2820080328>3.0.CO;2-DCrossRefPubMed
19.
20.
21.
Burger PC, Scheithauer BW, Vogel FS (2002) Surgical pathology of the nervous system and its coverings. Churchill-Livingstone, New York, pp 475–495
22.
Lopes MBS, Thapar K, Horvath E, Kowacs K (2006) Neoplasms of the sellar region. In: McLendon RE, Rosenblum MK, Bigner DD (eds) Russell and Rubinstein’s pathology of tumors of the nervous system, 7th edn. Hodder Arnold, London, pp 663–774
23.
Cushing H (1932) Intracranial tumors. Notes upon a series of two thousand verified cases with surgical mortality percentages pertaining thereto. Thomas, Springfield, pp 93–98
24.
Jackson H (1916) Craniopharyngeal duct tumors. J Am Med Assoc 66:1082–1084
25.
26.
27.
28.
29.
Kahn EA, Gosch HH, Seeger JF, Hicks SP (1973) Forty-five years experience with the craniopharyngiomas. Surg Neurol 1:5–12PubMed
30.
Petito CK, DeGirolami U, Earle KM (1976) Craniopharyngiomas: a clinical and pathological review. Cancer 37:1944–1952. doi:10.1002/1097-0142(197604)37:4<1944::AID-CNCR2820370446>3.0.CO;2-#CrossRefPubMed
31.
Adamson TE, Wiestler OD, Kleihues P, Yargil MG (1990) Correlation of clinical and pathological features in surgically treated craniopharyngiomas. J Neurosurg 73:12–17CrossRefPubMed
32.
Weiner HL, Wisoff JH, Rosenberg ME, Kupersmith MJ, Cohen H, Zagzag D, Shiminski-Maher T, Flamm ES, Epstein FJ, Miller DC (1994) Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery 35:1001–1011. doi:10.​1097/​00006123-199412000-00001 CrossRefPubMed
33.
34.
Crotty TB, Scheithauer BW, Young WF Jr, Davis DH, Shaw EG, Miller GM, Burger PC (1995) Papillary craniopharyngioma: a clinicopathological study of 48 cases. J Neurosurg 83:206–214CrossRefPubMed
35.
Halstead AE (1910) Remarks on the operative treatment of tumors of the hypophysis with the report of two cases operated on by an oro-nasal method. Surg Gynecol Obstet 10:494–502
36.
37.
38.
39.
40.
Lewis DD (1910) A contribution to the subject of tumors of the hypophysis. J Am Med Assoc 55:1002–1008
41.
42.
Love JG, Marshall TM (1950) Craniopharyngiomas (pituitary adamantinomas). Surg Gynecol Obstet 90:591–601PubMed
43.
Grant FC (1948) Surgical experience with tumors of the pituitary gland. J Am Med Assoc 136:668–671PubMed
44.
Müller R, Wohlfart G (1950) Craniopharyngiomas. Acta Med Scand 138:121–138PubMed
45.
Ingraham FD, Matson DD, McLaurin RL (1952) Cortisone and ACTH as an adjunct to the surgery of craniopharyngiomas. N Engl J Med 246:568–571PubMed
46.
47.
Horrax G (1954) Benign (favorable) types of brain tumor. The end results (up to twenty years), with statistics of mortality and useful survival. N Engl J Med 250:981–984PubMedCrossRef
48.
49.
50.
Gramegna A (1909) Un cas d’acromégalie traité par la radiothérapie. Rev Neurol 17:15–17
51.
Béclère A (1910) The radiotherapeutic treatment of tumours of the hypophysis, gigantism, and acromegaly. Arch Roentgen Ray 14:142–150
52.
Carpenter RC, Chamberlin GW, Frazier CH (1937) The treatment of hypophyseal stalk tumors by evacuation and irradiation. AJR Am J Roentgenol 38:162–177
53.
Kramer S, McKissock W, Concannon JP (1961) Craniopharyngiomas: treatment by combined surgery and radiation therapy. J Neurosurg 18:217–226CrossRefPubMed
54.
Leksell L (1952) The stereotaxic method and radiosurgery of the brain. Acta Chir Scand 102:316–319
55.
56.
Úlfarsson E, Lindquist C, Roberts M, Rähn T, Lindquist M, Thorén M, Lippitz B (2002) Gamma knife radiosurgery for craniopharyngiomas: long-term results in the first Swedish patients. J Neurosurg 97(Suppl 5):613–622PubMed
57.
58.
Combs SE, Thilmann C, Huber PE, Hoess A, Debus J, Schulz-Ertner D (2007) Achievement of long-term local control in patients with craniopharyngiomas using high precision stereotactic radiotherapy. Cancer 109:2308–2314. doi:10.​1002/​cncr.​22703 CrossRefPubMed
59.
Fahlbusch R, Honegger J, Paulus W, Huk W, Buchfelder M (1999) Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 90:237–250CrossRefPubMed
60.
61.
Karavitaki N, Brufani C, Warmert JT, Adams CBT, Richards P, Ansorge O, Shine B, Turner HE, Wass JAH (2005) Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf) 62:397–409. doi:10.​1111/​j.​1365-2265.​2005.​02231.​x CrossRef
Metadata
Title
Craniopharyngioma: historical notes
Authors
J. Lindholm
E. H. Nielsen
Publication date
01-12-2009
Publisher
Springer US
Published in
Pituitary / Issue 4/2009
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-008-0165-8

Other articles of this Issue 4/2009

Pituitary 4/2009 Go to the issue

Letter

Pituicytoma and isolated ACTH deficiency

OriginalPaper

Prevalence and clinical demographics of cerebral salt wasting in patients with aneurysmal subarachnoid hemorrhage

Case Report

Lymphocytic hypophysitis with associated thyroiditis in a man with aseptic meningitis

Letter

Confirmation of local amino acid sequence homology between human prolactin and the amyloid-related proteins

OriginalPaper

Ghrelin and GHRP-6-induced ACTH and cortisol release in thyrotoxicosis

OriginalPaper

Acromegaly: correlation between expression of somatostatin receptor subtypes and response to octreotide-lar treatment
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits